 |
Topic Index: Hypertension |
|
|
Topic Index: Hypertension |
H: Pathophysiology
|
Age-related norms |
|
|
Heart in hypertension |
|
|
End Organ Damage |
|
|
Kidney in hypertension |
|
|
Intracellular ionic composition |
|
|
Calcium |
|
|
Salt (sodium, chloride) sensitivity |
|
|
Sleep, sleep apnea |
|
|
Sympathetic nervous system |
|
|
Hormonal aberrations |
|
|
Coagulation abnormalities |
|
|
Genetics |
|
|
Vascular pathology |
|
|
Endothelium, Nitric Oxide |
|
|
Fetal origins, birth weight |
|
|
Stroke |
H: Exam and lab tests
|
|
Arm cuff |
|
|
Ambulatory monitoring |
|
|
White coat hypertension |
|
|
Tests for LVH |
|
|
Tests for early atherosclerosis |
H: Diagnosis
|
|
Preadolescent and adolescent |
|
|
Young adult through middle age |
|
|
Elderly |
H: Special problems
|
|
Women |
|
|
Outcomes |
|
|
Patients with lipid disorders |
|
|
Endocrine hypertension |
|
|
Pheochromocytoma |
|
|
Renovascular hypertension |
|
|
Renal transplant patients |
|
|
Ethnic populations |
|
|
Chronic renal insufficiency |
|
|
Drug-induced hypertension |
|
|
Hypercalciuria |
|
|
Smoking, ethanol, substance abuse |
|
|
Obesity, Insulin Resistance |
|
|
Dialysis patients |
|
|
Elderly |
H: Drug therapy
|
|
Calcium channel blockers |
|
|
ACE inhibitors |
|
|
Diuretics |
|
|
Beta blockers |
|
|
Alpha and alpha/beta blockers |
|
|
Sympatholytics |
|
|
Vasodilators |
|
|
Other drugs |
|
|
Compliance |
|
|
Cost-effectiveness |
|
|
Chronotherapeutics |
|
|
Multiple drugs, synergy |
|
|
Acute hypertensive crisis |
H: Non drug therapy
|
|
Stress reduction and biofeedback |
|
|
Dietary/electrolyte therapy |
|
|
Role of exercise |